IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS

#	Drug	Count
0	PYRAZINAMIDE	111
1	PYRAZINAMIDE TABLET	111
2	ISONIAZID	109
3	LAMIVUDINE	42
4	RIFAMPIN	37
5	EFAVIRENZ	36
6	LEVOFLOXACIN	30
7	LEVOFLOXACIN IN 5% DEXTROSE	30
8	EMTRICITABINE	24
9	TENOFOVIR DISOPROXIL FUMARATE	23

#	Drug	Count	Frequency
0	PRETOMANID	4	0.0580
1	STREPTOMYCIN	17	0.0175
2	PYRAZINAMIDE TABLET	111	0.0158
3	RIFABUTIN	16	0.0087
4	ISONIAZID	109	0.0087
5	RIFAMPIN	37	0.0055
6	ETHAMBUTOL HYDROCHLORIDE	8	0.0038
7	PENICILLIN G BENZATHINE	2	0.0037
8	ALBENDAZOLE	5	0.0037
9	ETHIONAMIDE	3	0.0036

#	Drug class	Count
0	Antimycobacterial [EPC]	116
1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	83
2	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	55
3	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	42
4	Corticosteroid [EPC]	41
5	Quinolone Antimicrobial [EPC]	37
6	Rifamycin Antibacterial [EPC]	37
7	Azole Antifungal [EPC]	25
8	Tumor Necrosis Factor Blocker [EPC]	21
9	Rifamycin Antimycobacterial [EPC]	16

#	Drug class	Count	Frequency
0	Antimycobacterial [EPC]	116	0.0079
1	Rifamycin Antimycobacterial [EPC]	16	0.0070
2	Anthelmintic [EPC]	5	0.0023
3	Rifamycin Antibacterial [EPC]	37	0.0018
4	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	55	0.0012
5	CCR5 Co-receptor Antagonist [EPC]	2	0.0010
6	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	42	0.0009
7	Lipid-based Polyene Antifungal [EPC]	10	0.0008
8	Oxazolidinone Antibacterial [EPC]	15	0.0008
9	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	83	0.0008